Stephen Mayo - 08 Jul 2022 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
Veer Bhavnagri as attorney-in-fact
Issuer symbol
ALLO
Transactions as of
08 Jul 2022
Net transactions value
$0
Form type
3
Filing time
12 Jul 2022, 16:37:21 UTC
Previous filing
01 Jun 2022
Next filing
21 Nov 2022

No securities are beneficially owned.